antigens oligonucleotid ao current promise therapeutic intervene duchess muscular dystrophy dmy model dystrophy premrna splice thereby specify restore read frame genre truncated semifunct protein challenge develop approach rel poor system ao delivery ineffici correct affect nonskelet muscle tissue include heart previous report impress active highsplic office restore follow single administer argininerich cellpenetr peptide cpp concur phosphorodiamid morpholino oligonucleotid pm pipepmo howe meghan under poorly understood report studi involve dose make derive connect assign pippmo peptidepmo comprise alter central hydrophobic core pipe illus certain chang sequence improv partial delete within abolish data india pip sequence critic specify modify region enhance result italic 